25-hydroxycholesterol has been researched along with Diabetic Glomerulosclerosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, BC; Liu, J; Lv, LL; Ma, KL; Ni, J; Ruan, XZ; Wang, CX; Wu, Y; Zhang, Y | 1 |
1 other study(ies) available for 25-hydroxycholesterol and Diabetic Glomerulosclerosis
Article | Year |
---|---|
Interaction of RAS activation and lipid disorders accelerates the progression of glomerulosclerosis.
Topics: Angiotensin II; Cholesterol; Diabetic Nephropathies; Disease Progression; Endoplasmic Reticulum; Gene Expression Regulation; Humans; Hydroxycholesterols; Intracellular Signaling Peptides and Proteins; Lipid Metabolism; Membrane Proteins; Mesangial Cells; ras Proteins; Receptor, Angiotensin, Type 1; Receptors, Lipoprotein; Renin-Angiotensin System; Sterol Regulatory Element Binding Protein 2; Sterol Regulatory Element Binding Proteins | 2013 |